Top Buy
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Edwards Lifesciences Corp. | 25 | 1 | 3 | 0 | €80.00 | €87.81 | 9.758% |
| Eledon Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €1.88 | €12.09 | 543.053% |
| Eli Lilly Corp. | 47 | 0 | 4 | 0 | €726.30 | €754.73 | 3.914% |
| Ensign Group Inc. | 8 | 0 | 1 | 0 | €110.00 | €116.50 | 5.906% |
| Esperion Therapeutis.Inc. | 13 | 0 | 2 | 0 | €1.94 | €8.39 | 332.613% |
| EssilorLuxottica SA | 3 | 0 | 0 | 0 | €201.50 | €204.50 | 1.489% |
| Evolus Inc | 6 | 1 | 1 | 1 | €10.90 | €20.26 | 85.829% |
| Exelixis Inc. | 15 | 0 | 0 | 0 | €21.80 | €26.01 | 19.295% |
| EyePoint Pharmaceuticals Inc. | 14 | 1 | 0 | 1 | €15.63 | €28.17 | 80.216% |
| Faes Farma S.A. | 1 | 0 | 0 | 0 | €3.40 | €6.00 | 76.730% |
| Fresenius Medical Care AG & Co KGaA ADR | 3 | 1 | 1 | 0 | €18.50 | €21.00 | 13.514% |
| Fresenius Medical Care AG & Co KGaA ST | 6 | 0 | 0 | 0 | €39.44 | €48.50 | 22.972% |
| Fresenius SE & Co. KGaA | 4 | 0 | 2 | 0 | €27.82 | - | - |
| G1 Therapeutics | 13 | 1 | 1 | 0 | €3.51 | €10.05 | 186.113% |
| Galmed Pharmaceuticals Ltd. | 4 | 0 | 0 | 0 | €0.36 | €61.56 | 16999.750% |
| Geron Corp. | 11 | 0 | 3 | 0 | €3.77 | €4.60 | 21.995% |
| Gerresheimer AG | 7 | 0 | 1 | 0 | €100.90 | €110.00 | 9.019% |
| Gilead Sciences Inc | 11 | 1 | 4 | 0 | €61.07 | €88.73 | 45.292% |
| Glycomimetics Inc. | 5 | 0 | 0 | 0 | €1.67 | €7.35 | 341.273% |
| GSK plc | 1 | 0 | 0 | 0 | €19.59 | - | - |
| GSK plc ADR | 4 | 0 | 0 | 0 | €38.20 | €35.00 | -8.377% |
| Haemonetics Corp. | 7 | 0 | 1 | 0 | €84.50 | €97.90 | 15.860% |
| Halozyme Therapeutics Inc. | 12 | 0 | 1 | 0 | €36.53 | €54.21 | 48.398% |
| HCA Holdings Inc. | 22 | 0 | 6 | 0 | €290.50 | €295.60 | 1.754% |
| Healthequity Inc. | 1 | 0 | 0 | 0 | €74.00 | €79.00 | 6.757% |